Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Registry Data Instead Of Randomized Control May Accelerate HF Device Trials

This article was originally published in The Gray Sheet

Executive Summary

Large heart failure registries will provide data that could be used in lieu of a randomized control in trials of new heart failure devices, according to participants at the annual Transcathether Cardiovascular Therapeutics HHS "Town Hall Meeting" Oct. 19
Advertisement

Related Content

Thoratec Projects Market Growth As CMS Revamps VAD Coverage Criteria
Thoratec Projects Market Growth As CMS Revamps VAD Coverage Criteria
Advertisement
UsernamePublicRestriction

Register

MT022846

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel